Human papilloma virus vaccine - Apimeds

Drug Profile

Human papilloma virus vaccine - Apimeds

Alternative Names: adeno-HPVVLP - Apimeds

Latest Information Update: 28 Jul 2016

Price : $50

At a glance

  • Originator Apimeds
  • Class Papillomavirus vaccines; Virus-like particle vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Preclinical Cervical cancer; Human papillomavirus infections

Most Recent Events

  • 28 Jul 2016 Preclinical trials in Cervical cancer (Prevention) in South Korea (Parenteral)
  • 28 Jul 2016 Preclinical trials in Human papillomavirus infections (Prevention) in South Korea (Parenteral)
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at so we can help.

Back to top